ArticleJournal of diabetes investigation2025
A multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice (PIONEER REAL Japan): Subgroup analyses.
Daisuke Yabe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.